Cliniphar Ltd (432A) Stock Price & News

All values in JPY	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	928.50M	928.50M	921.50M	921.50M
Cost of goods sold	769.50M	769.50M	759.00M	759.00M
Cost of revenue	769.50M	769.50M	759.00M	759.00M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	121.00M	121.00M	133.50M	133.50M
Operating expense	121.00M	121.00M	133.50M	133.50M
Total operating expenses	890.50M	890.50M	892.50M	892.50M
Operating income	38.00M	38.00M	29.00M	29.00M
Other non operating income	3.50M	3.50M	-6.50M	-6.50M
EBT including unusual items	41.00M	41.00M	32.50M	32.50M
EBT excluding unusual items	48.00M	48.00M	29.00M	29.00M
Income tax expense	-	-	-7.00M	-7.00M
Effective tax rate	-	-	-21.54%	-21.54%
Other operating expenses	-	-	-	-
Net income	41.00M	41.00M	39.50M	39.50M
Net profit margin	4.42%	4.42%	4.29%	4.29%
Earnings per share	-	-	-	-
Interest and investment income	8.00M	8.00M	8.00M	8.00M
Interest expense	-2.00M	-2.00M	-2.00M	-2.00M
Net interest expenses	6.00M	6.00M	6.00M	6.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	46.00M	46.00M	37.00M	37.00M
Gain or loss from assets sale	1.50M	1.50M	-	-

Finance